{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T15:51:05Z","timestamp":1785513065259,"version":"3.56.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016924","name":"National Cerebral and Cardiovascular Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016924","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Asia"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jacasi.2025.07.020","type":"journal-article","created":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T15:45:45Z","timestamp":1757778345000},"page":"1444-1453","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["CYP2C19 Polymorphism and Clopidogrel Efficacy in Long-Term Outcomes of Large-Artery Atherosclerotic Stroke"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3178-8171","authenticated-orcid":false,"given":"Takeshi","family":"Yoshimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yorito","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0071-7338","authenticated-orcid":false,"given":"Hiroyuki","family":"Ishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuriko","family":"Nakaoku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0100-376X","authenticated-orcid":false,"given":"Soshiro","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichiro","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ninomiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiro","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Ihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacasi.2025.07.020_bib1","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1474-4422(21)00252-0","article-title":"Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"20","author":"Feigin","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jacasi.2025.07.020_bib2","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1161\/STROKEAHA.120.028992","article-title":"Risk and secondary prevention of stroke recurrence: a population-base cohort study","volume":"51","author":"Flach","year":"2020","journal-title":"Stroke"},{"key":"10.1016\/j.jacasi.2025.07.020_bib3","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2004.038166","article-title":"Ten year recurrence after first ever stroke in a Japanese community: the Hisayama study","volume":"76","author":"Hata","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jacasi.2025.07.020_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.17037","article-title":"Association of CYP2C19 loss-of-function metabolizer status with stroke risk among Chinese patients treated with ticagrelor-aspirin vs clopidogrel-aspirin: a prespecified secondary analysis of a randomized clinical trial","volume":"6","author":"Xie","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacasi.2025.07.020_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2023-002436","article-title":"Role of genetic polymorphisms in clopidogrel response variability: a systematic review","volume":"10","author":"Lopez","year":"2023","journal-title":"Open Heart"},{"key":"10.1016\/j.jacasi.2025.07.020_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d4588","article-title":"Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis","volume":"343","author":"Bauer","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jacasi.2025.07.020_bib7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/CIRCULATIONAHA.116.024913","article-title":"Genetic polymorphisms and clopidogrel efficacy for acute ischemic stroke or transient ischemic attack: a systematic review and meta-analysis","volume":"135","author":"Pan","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacasi.2025.07.020_bib8","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1056\/NEJMoa2111749","article-title":"Ticagrelor versus clopidogrel in CYP2C19 loss-of-function carriers with stroke or TIA","volume":"385","author":"Wang","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacasi.2025.07.020_bib9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.5551\/jat.63369","article-title":"P2Y12 reaction units and clinical outcomes in acute large artery atherosclerotic stroke: a multicenter prospective study","volume":"30","author":"Fukuma","year":"2023","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jacasi.2025.07.020_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/cts.13792","article-title":"The association of CYP2C19 LoF alleles with adverse clinical outcomes in stroke patients taking clopidogrel: an updated meta-analysis","volume":"17","author":"Biswas","year":"2024","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.jacasi.2025.07.020_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2023.117281","article-title":"Association of thyroid peroxidase antibody with the RNF213 p.R4810K variant in ischemic stroke\/transient ischemic attack","volume":"382","author":"Yoshimoto","year":"2023","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacasi.2025.07.020_bib12","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jacasi.2023.03.011","article-title":"Amplified risk of intracranial artery stenosis\/occlusion associated with RNF213 p.R4810K in familial hypercholesterolemia","volume":"3","author":"Noda","year":"2023","journal-title":"JACC Asia"},{"key":"10.1016\/j.jacasi.2025.07.020_bib13","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jacasi.2023.05.002","article-title":"RNF213 p.R4810K variant increases the risk of vasospastic angina","volume":"3","author":"Ishiyama","year":"2023","journal-title":"JACC Asia"},{"key":"10.1016\/j.jacasi.2025.07.020_bib14","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000200029","article-title":"Effect of the RNF213 p.R4810K variant on the progression of intracranial artery stenosis: a 15-year follow-up study","volume":"8","author":"Okazaki","year":"2022","journal-title":"Neurol Genet"},{"issue":"6","key":"10.1016\/j.jacasi.2025.07.020_bib15","article-title":"Impact of the RNF213 p.R4810K variant on endovascular therapy for large-vessel occlusion stroke","author":"Yoshimoto","year":"2022","journal-title":"Stroke Vasc Interv Neurol"},{"issue":"6","key":"10.1016\/j.jacasi.2025.07.020_bib16","article-title":"Association of the RNF213 p.R4810K variant with the outer diameter of cervical arteries in patients with ischemic stroke","author":"Yamaguchi","year":"2022","journal-title":"Stroke Vasc Interv Neurol"},{"key":"10.1016\/j.jacasi.2025.07.020_bib17","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.5551\/jat.63379","article-title":"RNF213 p.R4810K variant carriers with intracranial arterial stenosis have a low atherosclerotic burden","volume":"29","author":"Ohara","year":"2022","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jacasi.2025.07.020_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.681743","article-title":"RNF213 p.R4810K (c.14429G > A) variant determines anatomical variations of the Circle of Willis in cerebrovascular disease","volume":"13","author":"Eto","year":"2021","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.jacasi.2025.07.020_bib19","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"147","author":"von","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacasi.2025.07.020_bib20","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.pharmthera.2007.09.004","article-title":"Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects","volume":"116","author":"Ingelman-Sundberg","year":"2007","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jacasi.2025.07.020_bib21","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJMoa0809171","article-title":"Cytochrome p-450 polymorphisms and response to clopidogrel","volume":"360","author":"Mega","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacasi.2025.07.020_bib22","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1159\/000529149","article-title":"Comparison of prasugrel and clopidogrel in thrombotic stroke patients with risk factors for ischemic stroke recurrence: an integrated analysis of PRASTRO-I, PRASTRO-II, and PRASTRO-III","volume":"52","author":"Kitazono","year":"2023","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.jacasi.2025.07.020_bib23","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1136\/jnis.2010.002345","article-title":"Reporting standards for angioplasty and stent-assisted angioplasty for intracranial atherosclerosis","volume":"2","author":"Schumacher","year":"2010","journal-title":"J Neurointerv Surg"},{"key":"10.1016\/j.jacasi.2025.07.020_bib24","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1161\/CIRCRESAHA.121.319915","article-title":"The impact of sex and gender on stroke","volume":"130","author":"Rexrode","year":"2022","journal-title":"Circ Res"},{"key":"10.1016\/j.jacasi.2025.07.020_bib25","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/S0140-6736(07)61448-2","article-title":"Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison","volume":"370","author":"Rothwell","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jacasi.2025.07.020_bib26","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1056\/NEJMoa1412981","article-title":"One-year risk of stroke after transient ischemic attack or minor stroke","volume":"374","author":"Amarenco","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacasi.2025.07.020_bib27","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacasi.2025.07.020_bib28","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies","volume":"375","author":"Sarwar","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jacasi.2025.07.020_bib29","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJM198904063201405","article-title":"Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial","volume":"320","author":"Iso","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacasi.2025.07.020_bib30","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","article-title":"Proportional hazards tests and diagnostics based on weighted residuals","volume":"81","author":"Grambsch","year":"1994","journal-title":"Biometrika"},{"key":"10.1016\/j.jacasi.2025.07.020_bib31","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.acvd.2013.06.055","article-title":"Cytochrome CYP2C19 polymorphism and risk of adverse clinical events in clopidogrel-treated patients: a meta-analysis based on 23,035 subjects","volume":"106","author":"Mao","year":"2013","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.jacasi.2025.07.020_bib32","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.09.014","article-title":"CYP2C19 genotype and early ischemic lesion recurrence in stroke patients treated with clopidogrel","volume":"24","author":"Jeong","year":"2015","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jacasi.2025.07.020_bib33","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12883-021-02127-6","article-title":"Association with CYP2C19 polymorphisms and clopidogrel in treatment of elderly stroke patients","volume":"21","author":"Li","year":"2021","journal-title":"BMC Neurol"},{"key":"10.1016\/j.jacasi.2025.07.020_bib34","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/jama.2009.1232","article-title":"Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy","volume":"302","author":"Shuldiner","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jacasi.2025.07.020_bib35","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJMoa0808227","article-title":"Genetic determinants of response to clopidogrel and cardiovascular events","volume":"360","author":"Simon","year":"2009","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.jacasi.2025.07.020_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2023.100573","article-title":"CYP2C19 genotype prevalence and association with recurrent myocardial infarction in British-South Asians treated with clopidogrel","volume":"2","author":"Magavern","year":"2023","journal-title":"JACC Adv"},{"key":"10.1016\/j.jacasi.2025.07.020_bib37","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/joim.13772","article-title":"Precision medicine in cardiovascular therapeutics: Evaluating the role of pharmacogenetic analysis prior to drug treatment","volume":"295","author":"Ingelman-Sundberg","year":"2024","journal-title":"J Intern Med"},{"key":"10.1016\/j.jacasi.2025.07.020_bib38","doi-asserted-by":"crossref","first-page":"e497","DOI":"10.1212\/WNL.0000000000201454","article-title":"Ticagrelor aspirin vs clopidogrel aspirin in CYP2C19 loss-of-function carriers with minor stroke or TIA stratified by risk profile","volume":"100","author":"Wang","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.jacasi.2025.07.020_bib39","doi-asserted-by":"crossref","first-page":"183","DOI":"10.12688\/wellcomeopenres.19202.1","article-title":"Development of a point-of-care genetic test for effective treatment of ischaemic stroke: an early model-based cost-effectiveness analysis","volume":"8","author":"Wright","year":"2023","journal-title":"Wellcome Open Res"},{"key":"10.1016\/j.jacasi.2025.07.020_bib40","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1177\/17474930221111898","article-title":"Cost-effectiveness of testing for CYP2C19 loss-of-function carriers following transient ischemic attack\/minor stroke: a Canadian perspective","volume":"18","author":"Micieli","year":"2023","journal-title":"Int J Stroke"},{"key":"10.1016\/j.jacasi.2025.07.020_bib41","doi-asserted-by":"crossref","first-page":"7383","DOI":"10.1038\/s41598-021-86824-9","article-title":"Cost-effectiveness of CYP2C19 genotyping to guide antiplatelet therapy for acute minor stroke and high-risk transient ischemic attack","volume":"11","author":"Cai","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacasi.2025.07.020_bib42","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s40261-020-00970-y","article-title":"Cost effectiveness of genotype-guided antiplatelet therapy in Asian ischemic stroke patients: ticagrelor as an alternative to clopidogrel in patients with CYP2C19 loss of function mutations","volume":"40","author":"Narasimhalu","year":"2020","journal-title":"Clin Drug Investig"}],"container-title":["JACC: Asia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772374725003953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772374725003953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T04:00:27Z","timestamp":1763784027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772374725003953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":42,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2772374725003953"],"URL":"https:\/\/doi.org\/10.1016\/j.jacasi.2025.07.020","relation":{},"ISSN":["2772-3747"],"issn-type":[{"value":"2772-3747","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CYP2C19 Polymorphism and Clopidogrel Efficacy in Long-Term Outcomes of Large-Artery Atherosclerotic Stroke","name":"articletitle","label":"Article Title"},{"value":"JACC: Asia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacasi.2025.07.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}